UNLABELLED: Alternations in the glycosylation of proteins have been described in connection with several cancers, including hepatocellular carcinoma (HCC) and colorectal cancer. Analytical tools, which use combination of liquid chromatography and mass spectrometry, allow precise and sensitive description of these changes. In this study, we use MRM and FT-ICR operating in full-MS scan, to determine ratios of intensities of specific glycopeptides in HCC, colorectal cancer, and liver metastasis of colorectal cancer. Haptoglobin, hemopexin and complement factor H were detected after albumin depletion and the N-linked glycopeptides with fucosylated glycans were compared with their non-fucosylated forms. In addition, sialylated forms of an O-linked glycopeptide of hemopexin were quantified in the same samples. We observe significant increase in fucosylation of all three proteins and increase in bi-sialylated O-glycopeptide of hemopexin in HCC of hepatitis C viral (HCV) etiology by both LC-MS methods. The results of the MRM and full-MS scan FT-ICR analyses provide comparable quantitative readouts in spite of chromatographic, mass spectrometric and data analysis differences. Our results suggest that both workflows allow adequate relative quantification of glycopeptides and suggest that HCC of HCV etiology differs in glycosylation from colorectal cancer and liver metastasis of colorectal cancer. SIGNIFICANCE: The article compares N- and O-glycosylation of several serum proteins in different diseases by a fast and easy sample preparation procedure in combination with high resolution Fourier transform ion cyclotron resonance mass spectrometry. The results show successful glycopeptides relative quantification in a complex peptide mixture by the high resolution instrument and the detection of glycan differences between the different types of cancer diseases. The presented method is comparable to conventional targeted MRM approach but allows additional curation of the data.

Department of Biochemistry Faculty of Sciences Charles University Prague Czech Republic

Department of Oncology Lombardi Comprehensive Cancer Center Georgetown University Washington DC USA

Institute of Microbiology v v i Czech Academy of Sciences Prague Czech Republic; Department of Biochemistry Faculty of Sciences Charles University Prague Czech Republic

Laboratory of Immunoanalysis Faculty Hospital in Pilsen Pilsen Czech Republic

Zobrazit více v PubMed

van Kooyk Y, Rabinovich GA. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat Immunol. 2008;9(6):593–601. PubMed

Taylor ME, Drickamer K. Paradigms for glycan-binding receptors in cell adhesion. Curr Opin Cell Biol. 2007;19(5):572–577. PubMed

Sharon N. Lectins: carbohydrate-specific reagents and biological recognition molecules. J Biol Chem. 2007;282(5):2753–2764. PubMed

Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell. 2006;126(5):855–867. PubMed

Nakano M, Nakagawa T, Ito T, Kitada T, Hijioka T, Kasahara A, Tajiri M, Wada Y, Taniguchi N, Miyoshi E. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers. Int J Cancer. 2008;122(10):2301–2309. PubMed

Blomme B, Van Steenkiste C, Callewaert N, van Vlierberghe H. Alteration of protein glycosylation in liver diseases. J Hepatol. 2009;50(3):592–603. PubMed

Wang M, Long RE, Comunale MA, Junaidi O, Marrero J, Di Bisceglie AM, Block TM, Mehta AS. Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol Biomark Prev. 2009;18(6):1914–1921. PubMed PMC

Saldova R, Royle L, Radcliffe CM, Abd hamid UM, Evans R, Arnold JN, Banks RE, Hutson R, Harvey DJ, Antrobus R, et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology. 2007;17(12):1344–1356. PubMed

Aebi M. N-linked protein glycosylation in the ER, Biochim. Biophys Acta Mol Cell Res. 2013;1833(11):2430–2437. PubMed

Schwarz F, Aebi M. Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol. 2011;21(5):576–582. PubMed

Pompach P, Brnakova Z, Sanda M, Wu J, Edwards N, Goldman R. Site-specific glycopeptides of haptoglobin in liver cirrhosis and hepatocellular carcinoma. Mol Cell Proteomics. 2013;12(5):1281–1293. PubMed PMC

Pompach P, Chandler KB, Lan R, Edwards N, Goldman R. Semi-automated identification of N-glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database search. J Proteome Res. 2012;11(3):1728–1740. PubMed PMC

Sanda M, Pompach P, Brnakova Z, Wu J, Makambi K, Goldman R. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS- MRM) analysis of site-specific glycopeptides of haptoglobin in liver disease. Mol Cell Proteomics. 2013;12(5):1294–1305. PubMed PMC

Zhu J, Lin Z, Wu J, Yin H, Dai J, Feng Z, Marrero J, Lubman DM. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies. J Proteome Res. 2014;13(6):2986–2997. PubMed PMC

Kaji H, Ocho M, Togayachi A, Kuno A, Sogabe M, Ohkura T, Nozaki H, Angata T, Chiba Y, Ozaki H, et al. Glycoproteomic discovery of serological biomarker candidates for HCV/HBV infection-associated liver fibrosis and hepatocellular carcinoma. J Proteome Res. 2013;12(6):2630–2640. PubMed

Campion B, Léger D, Wieruszeski JM, Montreuil J, Spik G. Presence of fucosylated triantennary, tetraantennary and pentaantennary glycans in transferrin synthesized by the human hepatocarcinoma cell line Hep G2. Eur J Biochem. 1989;184(2):405–413. PubMed

Barthel SR, Wiese GK, Cho J, Opperman MJ, Hays DL, Siddiqui J, Pienta KJ, Furie B, Dimitroff CJ. Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc Natl Acad Sci U S A. 2009;106(46):19491–19496. PubMed PMC

Higai K, Miyazaki N, Azuma Y, Matsumoto K. Transcriptional regulation of the fucosyltransferase VI gene in hepatocellular carcinoma cells. Glycoconj J. 2008;25(3):225–235. PubMed

Mathieu S, Gerolami R, Luis J, Carmona S, Kol O, Crescence L, Garcia S, Borentain P, El-Battari A. Introducing alpha(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growth. Int J Cancer. 2007;121(8):1680–1689. PubMed

Guo Q, Guo B, Wang Y, Wu J, Jiang W, Zhao S, Qiao S, Wu Y. Functional analysis of α1,3/4-fucosyltransferase VI in human hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2012;417(1):311–317. PubMed

Wei T, Liu Q, He F, Zhu W, Hu L, Guo L, Zhang J. The role of Nacetylglucosaminyltransferases V in the malignancy of human hepatocellular carcinoma. Exp Mol Pathol. 2012;93(1):8–17. PubMed

Du MQ, Hutchinson WL, Johnson PJ, Williams R. Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels. Cancer. 1991;67(2):476–480. PubMed

Taketa K, Sekiya C, Namiki M, Akamatsu K, Ohta Y, Endo Y, Kosaka K. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology. 1990;99(2):508–518. PubMed

Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, Satomura S, Schwartz ME. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol. 2007;102(10):2196–2205. PubMed

Benicky J, Sanda M, Pompach P, Wu J, Goldman R. Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver disease. Anal Chem. 2014;86(21):10716–10723. PubMed PMC

Tsutsumi M, Wang JS, Takada A. Microheterogeneity of serum glycoproteins in alcoholics: is desialo-transferrin the marker of chronic alcohol drinking or alcoholic liver injury? Alcohol Clin Exp Res. 1994;18(2):392–397. PubMed

Pompach P, Ashline DJ, Brnakova Z, Benicky J, Sanda M, Goldman R. Protein and site specificity of fucosylation in liver-secreted glycoproteins. J Proteome Res. 2014;13(12):5561–5569. PubMed PMC

Mori S, Aoyagi Y, Yanagi M, Suzuki Y, Asakura H. Serum Nacetylglucosaminyltransferase I11 activities in hepatocellular carcinoma. J Gastroenterol Hepatol. 1998;13(6):610–619. PubMed

Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, Callewaert N. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics. 2009;8(5):986–994. PubMed PMC

Stumpo KA, Reinhold VN. The N-glycome of human plasma research articles. J Proteome Res. 2010;9(9):4823–4830. PubMed PMC

Bekesova S, Kosti O, Chandler KB, Wu J, Madej HL, Brown KC, Simonyan V, Goldman R. N-glycans in liver-secreted and immunoglogulin-derived protein fractions. J Proteome. 2012;75(7):2216–2224. PubMed PMC

Kang P, Mechref Y, Klouckova I, Novotny MV. Solid-phase permethylation of glycans for mass spectrometric analysis, Rapid Commun. Mass Spectrom. 2005;19(23):3421–3428. PubMed PMC

Mechref Y, Novotny MV. Structural characterization of oligosaccharides using MALDI/TOF/TOF tandem mass spectrometry. Anal Chem. 2003;75(18):4895–4903. PubMed

Mechref Y, Novotny MV. Mass spectrometric mapping and sequencing of N-linked oligosaccharides derived from submicrogram amounts of glycoproteins. Anal Chem. 1998;70(3):455–463. PubMed

Christiansen MN, Kolarich D, Nevalainen H, Packer NH, Jensen PH. Challenges of determining o-glycopeptide heterogeneity: a fungal glucanase model system. Anal Chem. 2010;82(9):3500–3509. PubMed

Deshpande N, Jensen PH, Packer NH, Kolarich D. GlycoSpectrumScan: fishing glycopeptides from MS spectra of protease digests of human colostrum sIgA. J Proteome Res. 2010;9(2):1063–1075. PubMed

Mysling S, Palmisano G, Hojrup P, Thaysen-Andersen M. Utilizing ion-pairing hydrophilic interaction chromatography solid phase extraction for efficient glycopeptide enrichment in glycoproteomics. Anal Chem. 2010;82(13):5598–5609. PubMed

Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G. Enrichment of glycopeptides for glycan structure and attachment site identification. Nat Methods. 2009;6(11):809–811. PubMed

Guerrero A, Lerno L, Barile D, Lebrilla CB. Top-down analysis of highly post- translationally modified peptides by Fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom. 2014;26(3):453–459. PubMed PMC

Lee LY, Lin CH, Fanayan S, Packer NH, Thaysen-Andersen M. Differential site accessibility mechanistically explains subcellular-specific N-glycosylation determinants. Front Immunol. 2014 Aug;5:1–13. PubMed PMC

Pompach P, Brnakova Z, Sanda M, Wu J, Edwards N, Goldman R. Site-specific glycopeptides of haptoglobin in liver cirrhosis and hepatocellular carcinoma. Mol Cell Proteomics. 2013;12(5):1281–1293. PubMed PMC

Pompach P, Ashline DJ, Brnakova Z, Benicky J, Sanda M, Goldman R. Protein and site specificity of fucosylation in liver-secreted glycoproteins. 2014;13(12):5561–5569. PubMed PMC

Song E, Pyreddy S, Mechref Y. Quantification of glycopeptides by multiple reaction monitoring liquid chromatography/tandem mass spectrometry, Rapid Commun. Mass Spectrom. 2012;26(17):1941–1954. PubMed PMC

Hong Q, Lebrilla CB, Miyamoto S, Ruhaak LR. Absolute quantitation of immunoglobulin G and its glycopeptides using multiple reaction monitoring. Anal Chem. 2013;85(18):8585–8593. PubMed PMC

Ruhaak LR, Lebrilla CB. Applications of multiple reaction monitoring to clinical glycomics. Chromatographia. 2014;78(5–6):335–342. PubMed PMC

Kurogochi M, Matsushista T, Amano M, Furukawa J, Shinohara Y, Aoshima M, Nishimura SI. Sialic acid-focused quantitative mouse serum glycoproteomics by multiple reaction monitoring assay. Mol Cell Proteomics. 2010;9(11):2354–2368. PubMed PMC

Goldman R, Sanda M. Targeted methods for quantitative analysis of protein glycosylation, PROTEOMICS - Clin. Appl. 2015;9(1–2):17–32. PubMed PMC

Amster IJ. Fourier transform mass spectrometry. J Mass Spectrom. 1996;31(12):1325–1337.

Marshall AG, Hendrickson CL, Jackson GS. Fourier transform ion cyclotron resonance mass spectrometry: a primer. Mass Spectrom Rev. 1998;17(1):1–35. PubMed

Fenyo D, Chait BT. Protein identification using mass spectrometric information. Electrophoresis. 1998;19:998–1005. PubMed

Fu Q, Garnham CP, Elliott ST, Bovenkamp DE, Van Eyk JE. A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, albumin and IgG depletion, and two-dimensional gel electrophoresis. Proteomics. 2005;5(10):2656–2664. PubMed

Royle L, Campbell MP, Radcliffe CM, White DM, Harvey DJ, Abrahams JL, Kim YG, Henry GW, Shadick NA, Weinblatt ME, et al. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem. 2008;376(1):1–12. PubMed

Park SY, Lee SH, Kawasaki N, Itoh S, Kang K, Ryu SHee, Hashii N, Kim JM, Kim JY, Kim JHoe. α1-3/4 fucosylation at Asn 241 of β-haptoglobin is a novel marker for colon cancer: a combinatorial approach for development of glycan biomarkers. Int J Cancer. 2012;130(10):2366–2376. PubMed

Park SY, Yoon SJ, Jeong YT, Kim JM, Kim JY, Bernert B, Ullman T, Itzkowitz SH, Kim JH, Hakomori S. N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects. Int J Cancer. 2010;126(1):142–155. PubMed

Wuhrer M, Deelder AM, Hokke CH. Protein glycosylation analysis by liquid chromatography-mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2005;825(2):124–133. PubMed

Zielinska DF, Gnad F, Wiśniewski JR, Mann M. Precision mapping of an in vivo Nglycoproteome reveals rigid topological and sequence constraints. Cell. 2010;141(5):897–907. PubMed

Yang Z, Hancock WS. Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. J Chromatogr A. 2004;1053(1–2):79–88. PubMed

Zauner G, Deelder AM, Wuhrer M. Recent advances in hydrophilic interaction liquid chromatography (HILIC) for structural glycomics. Electrophoresis. 2011;32(24):3456–3466. PubMed

Karlsson NG, Wilson NL, Wirth HJ, Dawes P, Joshi H, Packer NH. Negative ion graphitised carbon nano-liquid chromatography/mass spectrometry increases sensitivity for glycoprotein oligosaccharide analysis. Rapid Commun Mass Spectrom. 2004;18(19):2282–2292. PubMed

Pabst M, Bondili JS, Stadlmann J, Mach L, Altmann F. Mass + retention time = structure: a strategy for the analysis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans. Anal Chem. 2007;79(13):5051–5057. PubMed

Lam MPY, Siu SO, Lau E, Mao X, Sun HZ, Chiu PCN, Yeung WSB, Cox DM, Chu IK. Online coupling of reverse-phase and hydrophilic interaction liquid chromatography for protein and glycoprotein characterization. Anal Bioanal Chem. 2010;398(2):791–804. PubMed PMC

Zauner G, Koeleman CAM, Deelder AM, Wuhrer M. Nano-HPLC-MS of glycopeptides obtained after nonspecific proteolysis. Methods Mol Biol. 2013;951:113–127. PubMed

Miyoshi E, Moriwaki K, Nakagawa T. Biological function of fucosylation in cancer biology. J Biochem. 2008;143(6):725–729. PubMed

Wuhrer M, Deelder AM, van der Burgt YEM. Mass spectrometric glycan rearrangements. Mass Spectrom Rev. 2011;30(4):664–680. PubMed

Sanda M, Pompach P, Benicky J, Goldman R. LC-MS3 quantification of O-glycopeptides in human serum. Electrophoresis. 2013;34(16):2342–4349. PubMed PMC

A Novel Monoallelic ALG5 Variant Causing Late-Onset ADPKD and Tubulointerstitial Fibrosis

Liquid chromatography and capillary electrophoresis in glycomic and glycoproteomic analysis

Comparison of Different HILIC Stationary Phases in the Separation of Hemopexin and Immunoglobulin G Glycopeptides and Their Isomers